Press Releases
Abstral ,Manufactured and packaged by Recipharm AB for Kyowa...
Approval to manufacture highly potent compound for breakthrough pain relief in cancer treatment granted. 23 September 2013, Recipharm Stockholm is pleased...
Press Releases
Global regulatory affairs specialist ELC Group appoints former MHRA...
ELC GROUP, one of the fastest-growing providers of regulatory affairs consulting services, today announced that John Warren, a former Expert Medical Assessor for the UK...
Press Releases
First Country in Europe launches LATUDA® – a...
LATUDA® (lurasidone), a new once-daily treatment for schizophrenia, is now available in Switzerland for the treatment of schizophrenia.Research has shown that the atypical antipsychotic, lurasidone,...
Press Releases
Veristat to Assist on Adaptive Enrichment Trial for Verastem’s...
Veristat LLC. a leading Boston-based clinical research organization today announced its advisory role on the implementation of an adaptive enrichment trial design for Verastem Inc....
Press Releases
Oncodesign and Banook Central Imaging sign a collaboration agreement...
Oncodesign, a contract research laboratory dedicated to the discovery of new anticancer therapies, and Banook Central Imaging, a company specializing in the centralized reading of...
Press Releases
Almac and Queen’s University, Belfast announce £13 million investment...
Almac Discovery has announced a £13million partnership with the Centre for Cancer Research and Cell Biology (CCRCB) at Queen’s University Belfast (QUB) to accelerate cancer-focused...
Press Releases
PharmaEngine Announces Achieving Patient Enrollment Goal in the Phase...
PharmaEngine Inc. announced today that together with PharmaEngine’s partner Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) we reach the goal of patient enrollment in the global phase...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.